Skip to main content
. 2009 Jun 27;30(18):2233–2240. doi: 10.1093/eurheartj/ehp253

Figure 2.

Figure 2

Timing of patient-assessed dyspnoea measurement relative to first dose or hospital admission. (A) Timing of patient assessment of dyspnoea relative to dosing by treatment group. (B) Timing of patient assessment of dyspnoea relative to time of hospital admission by treatment group.